Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.260
-0.010 (-0.44%)
Dec 23, 2024, 2:55 PM EST - Market open
Genelux Market Cap
Genelux has a market cap or net worth of $77.08 million as of December 23, 2024. Its market cap has decreased by -76.06% in one year.
Market Cap
77.08M
Enterprise Value
45.40M
1-Year Change
-76.06%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $77.08M, a decrease of -45.60%. That is a compound annual growth rate of -27.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 77.42M | -79.32% |
| Dec 29, 2023 | 374.31M | 164.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InspireMD | 78.25M |
| So-Young International | 78.25M |
| Cibus | 78.21M |
| FibroBiologics | 77.98M |
| PMV Pharmaceuticals | 77.62M |
| Entera Bio | 77.35M |
| Context Therapeutics | 76.50M |
| 111, Inc. | 75.38M |